StreetInsider.com News Articles

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Fri, 17 Jul 2026 08:30:00 -0400

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

DETROIT--(BUSINESS WIRE)-- Bayer, a global life sciences company, and Henry Ford Health today announced a strategic partnership to expand clinical trial opportunities for patients. The work brings together Bayer’s global drug development expertise with Henry Ford Health’s comprehensive clinical research program and its deep connection to the communities it serves.

“Clinical trials are often the first opportunity patients have to access cutting-edge treatments,” said Dr. David Lanfear, Chief Scientific Officer for Henry Ford Health. “Through this collaboration, we aim to make

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Fri, 17 Jul 2026 08:30:00 -0400

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Fri, 17 Jul 2026 08:30:00 -0400

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Fri, 17 Jul 2026 08:30:00 -0400

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Fri, 17 Jul 2026 08:30:00 -0400

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Fri, 17 Jul 2026 08:30:00 -0400

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Fri, 17 Jul 2026 08:30:00 -0400

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Fri, 17 Jul 2026 08:30:00 -0400

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Fri, 17 Jul 2026 08:30:00 -0400

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

Bayer and Henry Ford Health Announce Strategic Research Partnership to Expand Patient Access to Clinical Trials

Fri, 17 Jul 2026 08:30:00 -0400

Henry Ford Health selected as one of only four U.S. academic health systems in Bayer’s strategic research network

Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Tue, 14 Jul 2026 08:10:00 -0400

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months
Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently
Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time

AMES, Iowa--(BUSINESS WIRE)-- Sabanto, a leader in autonomous retrofit technology for agriculture, today announced an oversubscribed Series B funding led by Leaps by Bayer with participation by Sustainable Forward Capital, InnoVenture Iowa, Fulcrum Global Capital, DCVC, and Yara. The round will accelerate broad adoption of autonomous technology, expand customer base,

Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Tue, 14 Jul 2026 08:10:00 -0400

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months
Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently
Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time

Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Tue, 14 Jul 2026 08:10:00 -0400

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months
Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently
Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time

Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Tue, 14 Jul 2026 08:10:00 -0400

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months
Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently
Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time

Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Tue, 14 Jul 2026 08:10:00 -0400

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months
Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently
Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time

Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Tue, 14 Jul 2026 08:10:00 -0400

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months
Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently
Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time

Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Tue, 14 Jul 2026 08:10:00 -0400

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months
Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently
Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time

Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Tue, 14 Jul 2026 08:10:00 -0400

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months
Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently
Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time

Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Tue, 14 Jul 2026 08:10:00 -0400

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months
Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently
Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time

Sabanto and Leaps by Bayer Announce Oversubscribed Series B Financing to Scale Autonomous Technology for Row Crop Farming

Tue, 14 Jul 2026 08:10:00 -0400

Funding supports commercialization and sales growth expansion, targeting hundreds of new farms in the next 12 months
Autonomy technology is designed to lower capital expenditures and unlock the ability to scale operations more efficiently
Sabanto’s physical AI makes swarm operations possible so that growers can replace horsepower with time

Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR60 at Barclays

Tue, 14 Jul 2026 04:51:16 -0400

Barclays analyst James Gordon raised the price target on Bayer AG (BAYN:GR) (OTC: BAYRY) to EUR60.00 (from EUR50.00) while maintaining a Overweight rating.

Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR60 at Barclays

Tue, 14 Jul 2026 04:51:16 -0400

Barclays analyst James Gordon raised the price target on Bayer AG (BAYN:GR) (OTC: BAYRY) to EUR60.00 (from EUR50.00) while maintaining a Overweight rating.

Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR60 at Barclays

Tue, 14 Jul 2026 04:51:16 -0400

Barclays analyst James Gordon raised the price target on Bayer AG (BAYN:GR) (OTC: BAYRY) to EUR60.00 (from EUR50.00) while maintaining a Overweight rating.

Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR60 at Barclays

Tue, 14 Jul 2026 04:51:16 -0400

Barclays analyst James Gordon raised the price target on Bayer AG (BAYN:GR) (OTC: BAYRY) to EUR60.00 (from EUR50.00) while maintaining a Overweight rating.

Bayer AG (BAYN:GR) (BAYRY) PT Raised to EUR65 at Morgan Stanley

Thu, 09 Jul 2026 07:42:35 -0400

Morgan Stanley analyst Thibault Boutherin raised the price target on Bayer AG (BAYN:GR) (OTC: BAYRY) to EUR65.00 (from EUR53.00) while maintaining a Overweight rating.